Literature DB >> 2745212

Hypoxia and reoxygenation in human melanoma xenografts.

E K Rofstad1.   

Abstract

Tumor hypoxia and reoxygenation pattern following single dose (10.0 Gy) and fractionated (7 fractions of 2.0 Gy, 1 fraction per day) irradiation were studied in five human melanoma xenograft lines using the paired survival curve method. The hypoxic fractions differed significantly among the melanoma lines; they were found to be 6 +/- 3% (E.E.), 22 +/- 8% (E.F.), 31 +/- 11% (G.E.), 45 +/- 17% (M.F.), and 15 +/- 5% (V.N.). There were no clear correlations between hypoxic fraction and tumor volume-doubling time or vascular density, suggesting that intrinsic cellular characteristics, for example, rate of oxygen consumption and ability to retain clonogenicity under hypoxic stress, also may play an important role for the magnitude of the hypoxic fractions in the melanomas. Reoxygenation was rapid and extensive in all melanoma lines; 12-24 hr after the single dose irradiation or the last fraction of the fractionated irradiation, the hypoxic fractions were similar to those in untreated tumors and stayed at that level up to at least 10 days after irradiation. The hypoxic fractions 1-10 days after irradiation tended to be higher after fractionated than after single dose irradiation, but the differences were not statistically significant. There was a positive correlation between the hypoxic fractions in untreated tumors and the hypoxic fractions after irradiation and reoxygenation, suggesting that it may be possible to predict radiation resistance caused by hypoxia from the hypoxic fractions in tumors before start of radiation therapy. However, hypoxia is probably not a major cause of failure in the radiation therapy of malignant melanoma.

Entities:  

Mesh:

Year:  1989        PMID: 2745212     DOI: 10.1016/0360-3016(89)90374-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?

Authors:  T Auberger; B Thürriegl; T Freude; L Weissfloch; R Senekowitsch-Schmidke; P Kneschaurek; F M Wagner; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors:  Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

3.  Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management.

Authors:  Pooya Jahanshahi; Nadim Nasr; Keith Unger; Ali Batouli; Gregory J Gagnon
Journal:  Front Oncol       Date:  2012-11-15       Impact factor: 6.244

4.  PLD-repair in human melanoma xenografts following single dose and fractionated irradiation.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

5.  Growth rates or radiobiological hypoxia are not correlated with local metabolite content in human melanoma xenografts with similar vascular network.

Authors:  M Kroeger; S Walenta; E K Rofstad; W Mueller-Klieser
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

6.  Asc-1 Transporter (SLC7A10): Homology Models And Molecular Dynamics Insights Into The First Steps Of The Transport Mechanism.

Authors:  Afaf Mikou; Alexandre Cabayé; Anne Goupil; Hugues-Olivier Bertrand; Jean-Pierre Mothet; Francine C Acher
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.